Renal cell carcinoma laboratory findings: Difference between revisions
Jump to navigation
Jump to search
Rim Halaby (talk | contribs) |
Rim Halaby (talk | contribs) |
||
Line 3: | Line 3: | ||
==Overview== | ==Overview== | ||
Lab work-up may show findings of renal or hepatic involvement. While polycythemia is classically associated with increased production of erythropoetin, anemia is a much more common finding. Finally, hypercalcemia should always be evaluated for in all patients with renal cell carcinoma. | |||
==Laboratory Findings== | ==Laboratory Findings== |
Revision as of 19:47, 12 January 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Renal cell carcinoma Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Renal cell carcinoma laboratory findings On the Web |
American Roentgen Ray Society Images of Renal cell carcinoma laboratory findings |
Risk calculators and risk factors for Renal cell carcinoma laboratory findings |
Overview
Lab work-up may show findings of renal or hepatic involvement. While polycythemia is classically associated with increased production of erythropoetin, anemia is a much more common finding. Finally, hypercalcemia should always be evaluated for in all patients with renal cell carcinoma.
Laboratory Findings
Lab findings are generally unspecific. The following laboratory abnormalities may be found in patients with renal cell carcinoma:
- Anemia
- Polycythemia
- Hypercalcemia
- Elevated ESR
- Elevated liver function tests
- Elevated alkaline phosphatase (ALP)
- Elevated lactate dehydrogenase (LDH)
- Elevated serum creatinine
- Hematuria
- Cancer cells on urine cytology